Vodis Pharmaceuticals (VP) News Today → Your Money is Not Safe (From American Alternative) (Ad) Free VP Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™tmcnet.com - March 27 at 1:27 PMStates' drug pricing boards off to a slow startmsn.com - March 22 at 8:16 AMVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Callmsn.com - February 25 at 2:28 PMAbivax appoints Ana Sharma as Vice President, Global Head of Qualitymarkets.businessinsider.com - February 7 at 8:56 AMMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Healthmarkets.businessinsider.com - January 24 at 1:10 PMDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023msn.com - December 14 at 3:30 PMBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsmsn.com - December 7 at 3:45 PMThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsabcnews.go.com - December 7 at 9:38 AMAmneal Pharma in pact with Strides to launch generic Vascepamsn.com - December 1 at 3:25 PMAnavex Life Sciences Appoints Senior VP of Regulatory Affairsmarkets.businessinsider.com - November 6 at 8:21 AMXpeng's vice president suspended amid corruption investigation in supply chain managementfoxnews.com - October 14 at 11:38 PMLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drugmarketwatch.com - October 9 at 6:33 PMStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Integamarkets.businessinsider.com - October 4 at 6:44 AMVice Presidentnewsweek.com - September 19 at 1:02 PMRepublican voters want Donald Trump. And his vice president? How about more Trump?usatoday.com - August 28 at 4:23 AMTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesnews.yahoo.com - August 22 at 4:12 AMVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcriptmsn.com - August 1 at 10:03 PMWhat has Kamala Harris done as vice president?news.yahoo.com - May 29 at 8:36 AMVice President Kamala Harris: Latest Newsnytimes.com - March 31 at 8:46 AMIonis announces GSK has advanced bepirovirsen into Phase 3 developmentyahoo.com - February 1 at 10:04 AMZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)yahoo.com - January 27 at 5:58 PMThe way Medicare will negotiate down prescription drug prices takes shapemarketwatch.com - January 12 at 1:17 AMGlenmark Pharmaceuticals launches congestive heart failure injection in United Statesmsn.com - January 10 at 1:16 PMMore families facing price shocks for lifesaving children's medicationsmsn.com - January 7 at 10:25 AMFDA to review preventative option for RSV in infants, developers saycnn.com - January 6 at 8:17 AMNew York doctors now required to prescribe naloxone to some patients on opioid painkillersmsn.com - January 4 at 7:00 AMVanda Pharma Says Phase II Study Of VQW-765 To Treat Anxiety Showed Lower Stress Levelsmarkets.businessinsider.com - December 2 at 7:49 AMVertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call Transcriptmsn.com - October 27 at 10:29 PMRVL Pharmaceuticals: Chapter 2 - A Developing Quandaryseekingalpha.com - September 22 at 4:08 PMGnomestar Craft Inc (GNOM)investing.com - September 17 at 3:15 PMJenaValve Completes Enrollment in the ALIGN-AR IDE Clinical Trialfinance.yahoo.com - September 14 at 7:09 AMKyverna Therapeutics Names Cell Therapy Expert Tom Van Blarcom, Ph.D., as Senior Vice President, Head of Researchmarkets.businessinsider.com - August 23 at 8:12 AMBig pharma sick as the US moves to negotiate drug pricesmsn.com - August 13 at 5:14 AMAnalysis: U.S. move to negotiate drug prices a rare defeat for Big Pharmamsn.com - August 12 at 10:10 AMFacing price controls, pharma industry cranks up heat on Congressmsn.com - August 12 at 10:10 AMVerrica Pharmaceuticals Inc. Investors: Company Investigated by the Portnoy Law Firmapnews.com - June 27 at 1:34 PMVRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)benzinga.com - June 13 at 5:26 PMBlack Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as Chief Medical Officertmcnet.com - June 1 at 8:06 AMVanda Pharmaceuticals: Strong Pipeline Developments To Power Long-Term Upsideseekingalpha.com - May 17 at 5:02 PMAcasti Pharma to Present at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on April 28thapnews.com - April 25 at 1:06 PM Get Vodis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter. Email Address Your Money is Not Safe (Ad)Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below… CLICK HERE TO GET YOUR GUIDE NOW VP Media Mentions By Week VP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VP News Sentiment▼0.000.61▲Average Medical News Sentiment VP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VP Articles This Week▼20▲VP Articles Average Week Get Vodis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DCNN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:VP) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vodis Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.